Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide-Reference-Cited by-同舟云学术

Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide

Published:2012-02-21 Issue:6 Volume:106 Page:1153-1159
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Young R J,Tin A W,Brown N J,Jitlal M,Lee S M,Woll P J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201250.pdf

Reference26 articles.

1. Bertolini F, Mingrone W, Alietti A, Ferrucci PF, Cocorocchio E, Peccatori F, Cinieri S, Mancuso P, Corsini C, Burlini A, Zucca E, Martinelli G ( 2001 ) Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers . Ann Oncol 12 : 987 – 990

2. D’Amato RJ, Loughnan MS, Flynn E, Folkman J ( 1994 ) Thalidomide is an inhibitor of angiogenesis . Proc Natl Acad Sci USA 91 : 4082 – 4085

3. Dowlati A, Gray R, Sandler AB, Schiller JH, Johnson DH ( 2008 ) Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab – an Eastern Cooperative Oncology Group Study . Clin Cancer Res 14 : 1407 – 1412

4. Dredge K, Marriott JB, Macdonald CD, Man HW, Chen R, Muller GW, Stirling D, Dalgleish AG ( 2002 ) Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects . Br J Cancer 87 : 1166 – 1172

5. Dudek AZ, Lesniewski-Kmak K, Larson T, Dragnev K, Isaksson R, Gupta V, Maddaus MA, Kratzke RA ( 2009 ) Phase II trial of neoadjuvant therapy with carboplatin, gemcitabine plus thalidomide for stages IIB and III non-small cell lung cancer . J Thorac Oncol 4 : 969 – 975

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade;Cytokine;2023-03

2. Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action;Frontiers in Oncology;2022-07-29

3. Soluble intercellular cell adhesion molecule-1 in lung cancer: A meta-analysis;Pathology - Research and Practice;2020-10

4. Large‐scale production, purification, and function of a tumor multi‐epitope vaccine: Peptibody with bFGF/VEGFA;Engineering in Life Sciences;2020-07-29

5. The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA;Frontiers in Oncology;2020-07-17